Renal cell carcinoma (RCC), also known as a gurnistical tumor, is a common form of adult kidney cancer arising from the renal tubule. It is notoriously resistant to chemotherapy and radiation therapy, so the clinical outcome is usually poor in advantage RCC. This antibody can be used to classify the Primary Renal Cell Carcinomas and Metastatic Renal Cell Carcinomas due to its immunoreactivities of approximately 90% and 85, respectively.

• IHC726-RCC Datasheet - IVD

• MSDS

CLONE:
IHC726

ISOTYPE:


HOST SPECIES:
Mouse

CLONALITY:
Monoclonal

POSITIVE CONTROL:
Kidney, Renal Cell Carcinoma

DILUTION RANGE:


INTENDED USE/REG. STATUS:
IVD